IMPORTANCE Recent data have suggested that disease biology and outcome of colon cancer may differ between right-sided and left-sided tumors. However, the literature on the prognostic value of tumor laterality is conflicting.
C olorectal cancer (CRC) is the second leading cause of cancer death in the Western world. 1 In recent years, a number of prognostic factors have been identified to guide therapeutic decision making. The extent to which the location of the primary tumor influences disease outcome is controversial. The hypothesis that proximal and distal CRCs represent distinct entities originated in the late 1980s.
2-4 Anatomically, the right and left colon arise from different embryonic origins; the proximal colon arises from the midgut and receives its main blood supply via the superior mesenteric artery, whereas the distal colon arises from the hindgut and is supplied by the inferior mesenteric artery. A variety of histological 5,6 and genetic 7-11 differences between the right and left colon have been described. Clinically, studies [12] [13] [14] have
shown that patients with right-sided colon cancer are older and more likely female, are initially seen with more advanced tumor stage, and are more likely to have poorly differentiated tumors. Several population-based studies [15] [16] [17] [18] [19] have explored the prognostic relevance of laterality in CRC, with conflicting results. A recent meta-analysis 20 of 15 studies reported inferior survival for patients with right-sided colon cancer (hazard ratio [HR], 1.14). Several presentations at the 2016 American Society of Oncology annual meeting and the 2016 European Society of Medical Oncology annual meeting also described inferior survival among patients with right-sided metastatic CRC, 18 especially in those with RAS wild-type tumors.
21-24
These apparently contradictory findings have renewed our interest in understanding the correlation between primary tumor location and prognosis in both nonmetastatic and metastatic CRC. We undertook a population-based study of patients with resected early-stage colon cancer to further evaluate the prognostic value of disease laterality.
Methods

Study Design and Study Population
This population-based retrospective cohort study explored the association between laterality and outcome of patients with resected colon cancer in the Canadian province of Ontario. Ontario has a population of approximately 13.5 million people and has a single-payer universal health insurance program. We used the Ontario Cancer Registry (OCR) to identify all incident cases of colon cancer in Ontario diagnosed between 2000 and 2008.
To reduce the possibility of locally recurrent disease, we restricted the cohort to patients who underwent primary tumor resection within 6 months of diagnosis. 
Data Sources and Linkage
The OCR is a passive, population-based cancer registry that captures diagnostic and demographic information on at least 98% of all incident cases of cancer in the province of Ontario. 25 The OCR also provides information about vital status and cause of death. Records of hospitalization from the Canadian Institute for Health Information contain information about surgical interventions; these records are known to be complete. 26 Provincial physician billing records from the Ontario Health Insurance Plan, treatment records from regional cancer centers, and provincial records of chemotherapy delivery were used to identify chemotherapy use. Surgical pathology reports were obtained from the OCR for a random sample of 25% of cases. A team of trained data abstractors manually reviewed these pathology reports and entered information about laterality, extent of disease, and surgical procedure into an electronic database. Data sets were linked using unique encoded identifiers and analyzed at the Institute for Clinical Evaluative Sciences.
Measures and Outcomes
Indicators of the socioeconomic status of the community in which patients resided at diagnosis were linked as described previously. 27 Quintiles of the median household income were based on the household income distribution for the entire province of Ontario. Quintile 1 represents the communities where the poorest 20% of the Ontario population resided. Comorbidity was classified using the Charlson Comorbidity Index modified for administrative data. 28 Adjuvant chemotherapy was defined as chemotherapy given within 16 weeks after resection of the primary tumor. Right-sided colon cancer was defined as any tumor arising in the cecum, ascending colon, hepatic flexure, or transverse colon. Left-sided colon cancer was defined as any tumor arising in the splenic flexure, descending colon, sigmoid colon, or rectosigmoid colon. Overall survival (OS) and cancer-specific survival (CSS) were measured from the time of resection of the primary CRC. To account for possible cause of death miscoding, CSS included death from
Key Points
Question Is there an association between tumor laterality and prognosis in early-stage colon cancer?
Findings In this population-based cohort study, there was no association between tumor sidedness and overall survival or cancer-specific survival among patients with stage I to III colon cancer.
Meaning
The observation that laterality is associated with survival in advanced colorectal cancer may not extend to patients with early-stage disease.
any cancer. Complete information about vital status in the OCR was available up to December 31, 2012; cause of death was available up to December 31, 2010.
Statistical Analysis
Comparisons of proportions between study groups were made using the χ 2 test. The OS and CSS were determined using the Kaplan-Meier method. Factors associated with laterality were evaluated using log binomial regression. Factors associated with OS or CSS were evaluated using the Cox proportional hazards regression model. Results were considered statistically significant at P < .05. All analyses were performed using statistical software (SAS, version 9.4; SAS Institute Inc).
Results
Study Population
Linked administrative databases identified 25 613 potentially eligible patients who underwent surgery between 2002 and 2008. Surgical pathology reports were reviewed for 7519 cases; 270 (3.6%) of these cases were excluded due to nonadenocarcinoma histology (n = 56), rectal cancer (n = 134), inconsistent dates between diagnosis and surgery (n = 36), and delivery of preoperative chemotherapy (n = 44); also excluded were patients with stage IV (n = 443) or stage 0 (n = 26) disease (eFigure in the Supplement). Among the remaining 6780 patients with stage I, II, or III colon cancer, 83 (1.2%) were excluded due to unknown lymph node count and 332 (4.9%) due to missing or bilateral laterality classification. The final study population consisted of 6365 patients.
Patient Characteristics
Characteristics of the study population are listed in 
Factors Associated With Survival
Factors associated with long-term survival are listed in Table 2 . In adjusted analyses, laterality was not associated with differences in long-term survival: the HRs were 1.00 (95% CI, 0.92-1.08) for OS and 1.00 (95% CI, 0.91-1.10) for CSS. Stage-specific Cox proportional hazards regression model analyses (Table 3 and We undertook exploratory analyses within the stage III subset to identify prognostic factors that may differ between rightsided and left-sided disease. There was no evidence of interaction between laterality and benefit from adjuvant chemotherapy by test for interaction: the HRs for OS were 0.43 (95% CI, 0.37-0.50) for left-sided tumors and 0.46 (95% CI, 0.40-0.54) for right-sided tumors (P = .52), while the HRs for CSS were 0.41 (95% CI, 0.34-0.49) for left-sided tumors and 0.45 (95% CI, 0.38-0.54) for right-sided tumors (P = .41). There was some evidence of interaction between laterality and histological grade (P = .09 for OS and P = .02 for CSS by test for interaction). Stage-specific Cox proportional hazards regression model analyses revealed that poorly differentiated histology was associated with a larger effect size in left-sided colon cancer 
Discussion
In this population-based cohort study, we explored the extent to which disease laterality is associated with survival among patients with early-stage colon cancer. Several important findings have emerged. First, older, female patients, with greater comorbidity, are more likely to have right-sided colon cancer. Second, we found that right-sided cancers are more likely to have a higher T stage, to be poorly differentiated, and to be node negative. Third, our results do not demonstrate any significant difference in long-term survival between rightsided and left-sided colon cancers.
Our It is important to highlight that most of these studies evaluated OS (rather than CSS) and did not adjust for comorbidity. Given the well-known association between more advanced age and right-sided disease, it is possible that results of some studies may be biased by confounding due to unmeasured comorbidity. This conjecture is supported by the observation that, among those studies that evaluated CSS, outcomes were not inferior for right-sided colon cancer.
Limitations and Strengths
Our study should be interpreted in the context of certain methodological limitations. The study population was identified using linked administrative databases that do not include information regarding various known prognostic factors in colon cancer, such as smoking status, diet, or race/ethnicity. In addition, information on performance status was not collected. Therefore, residual confounding is a major limitation in this study. In addition, because the correlation between medical record-derived and International Classification of Diseases, Ninth Revision, code-derived Charlson Comorbidity Index is moderate, 30 our adjustment for the Charlson Comorbidity Index may not be optimal. As in most populationbased studies, we were unable to determine the molecular subtype of the tumor, which likely has a role in prognosis. Specifically, tumors that exhibit microsatellite instability (MSI) have been shown to have better prognosis, and it is estimated that 20% to 25% of stage II and 15% of stage III right-sided cancers are MSI positive. 31 In an attempt to understand why rightsided cancers may have worse cancer-specific mortality, despite being more likely to be MSI positive, Phipps et al 32 correlated MSI status with oncologic outcomes of more than 3000 patients with CRC. Patients who had higher cancerspecific mortality were limited to those with microsatellitestable tumors. Some of those patients also had other mutations in their tumor, including CIMP and BRAF, which are associated with poor prognosis. The major strengths of this study include the large sample size and the fact that we captured all cases of resected earlystage colon cancer using the OCR. By reviewing all surgical pathology reports, we were also able to control for important disease-related factors (eg, grade and lymphovascular invasion). Finally, we describe OS and CSS; CSS may be less vulnerable than OS to confounding by age and comorbidity, which is relevant given the known differences in patient case mix between right-sided and left-sided colon cancer. To our knowledge, this investigation is the largest study that has evaluated both OS and CSS.
Conclusions
In summary, we found no strong association between disease laterality and outcome of early-stage resected colon cancer. Results of previously published studies are not consistent; therefore, the extent to which disease laterality is prognostic remains uncertain. Studies in this field should control for comorbidity and explore CSS in addition to OS. Future research that can incorporate molecular and genetic elements of disease will provide important insights into how tumor location is associated with patient outcome. 
